Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1985 Jan;38(1):86–91. doi: 10.1136/jcp.38.1.86

Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.

W A Vel, F Namavar, A M Verweij-van Vught, A N Pubben, D M MacLaren
PMCID: PMC499078  PMID: 3881478

Abstract

The inhibitory effect of Bacteroides fragilis on the in vitro killing of Escherichia coli by polymorphonuclear leucocytes was studied with two pairs of E coli and B fragilis isolated from human wound infections. Both B fragilis strains behaved similarly: they inhibited the killing of one E coli strain, while the killing of the other E coli strain was not affected. The different behaviour of the two E coli strains depended on their need for fresh serum in the killing by the polymorphonuclear leucocytes. The inhibitory effect of the B fragilis strains could be completely accounted for by their effect on complement.

Full text

PDF
86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babb J. L., Cummins C. S. Encapsulation of Bacteroides species. Infect Immun. 1978 Mar;19(3):1088–1091. doi: 10.1128/iai.19.3.1088-1091.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Connolly J. C., McLean C., Tabaqchali S. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing. J Med Microbiol. 1984 Jun;17(3):259–271. doi: 10.1099/00222615-17-3-259. [DOI] [PubMed] [Google Scholar]
  3. Ingham H. R., Sisson P. R., Tharagonnet D., Selkon J. B., Codd A. A. Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet. 1977 Dec 17;2(8051):1252–1254. doi: 10.1016/s0140-6736(77)92662-9. [DOI] [PubMed] [Google Scholar]
  4. Jones G. R., Gemmell C. G. Impairment by Bacteroides species of opsonisation and phagocytosis of enterobacteria. J Med Microbiol. 1982 Aug;15(3):351–361. doi: 10.1099/00222615-15-3-351. [DOI] [PubMed] [Google Scholar]
  5. Kasper D. L., Onderdonk A. B., Polk B. F., Bartlett J. G. Surface antigens as virulence factors in infection with Bacteroides fragilis. Rev Infect Dis. 1979 Mar-Apr;1(2):278–290. doi: 10.1093/clinids/1.2.278. [DOI] [PubMed] [Google Scholar]
  6. Kelly M. J. The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds. J Med Microbiol. 1978 Nov;11(4):513–523. doi: 10.1099/00222615-11-4-513. [DOI] [PubMed] [Google Scholar]
  7. Namavar F., Verweij A. M., Bal M., van Steenbergen T. J., de Graaff J., MacLaren D. M. Effect of anaerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytes. Infect Immun. 1983 Jun;40(3):930–935. doi: 10.1128/iai.40.3.930-935.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Namavar F., van Vught A. M., MacLaren D. M. Bacterial synergy in mixed aerobic/anaerobic infections. Lancet. 1980 Mar 22;1(8169):659–659. [PubMed] [Google Scholar]
  9. Reid J. H., Patrick S. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis. J Med Microbiol. 1984 Jun;17(3):247–257. doi: 10.1099/00222615-17-3-247. [DOI] [PubMed] [Google Scholar]
  10. Reznikov M., Finlay-Jones J. J., McDonald P. J. Effect of Bacteroides fragilis on the peritoneal clearance of Escherichia coli in mice. Infect Immun. 1981 Apr;32(1):398–399. doi: 10.1128/iai.32.1.398-399.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Shah H. N., Williams R. A., Bowden G. H., Hardie J. M. Comparison of the biochemical properties of Bacteroides melaninogenicus from human dental plaque and other sites. J Appl Bacteriol. 1976 Dec;41(3):473–495. doi: 10.1111/j.1365-2672.1976.tb00660.x. [DOI] [PubMed] [Google Scholar]
  12. Simon G. L., Klempner M. S., Kasper D. L., Gorbach S. L. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis. 1982 Jan;145(1):72–77. doi: 10.1093/infdis/145.1.72. [DOI] [PubMed] [Google Scholar]
  13. Tofte R. W., Peterson P. K., Schmeling D., Bracke J., Kim Y., Quie P. G. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin. Infect Immun. 1980 Mar;27(3):784–792. doi: 10.1128/iai.27.3.784-792.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wade B. H., Kasper D. L., Mandell G. L. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria. J Antimicrob Chemother. 1983 Oct;12 (Suppl 100):51–62. doi: 10.1093/jac/12.suppl_c.51. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES